KaloCyte Patents – Insights & Stats (Updated 2023)

KaloCyte has a total of 19 patents globally, out of which 1 patent has been granted. Of these 19 patents, more than 89% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of KaloCyte.

KaloCyte was founded in 2016. Kalocyte is a healthcare biotech company in the pre-clinical stage that offers artificial red blood cell substitutes for services linked to trauma care. The company creates a proven proof of concept for ErythroMer, a dried artificial red blood cell inspired by biology that is intended to be used in situations when stored red blood cells are hard to come by, unfavourable, or insufficient.

Do read about some of the most popular patents of KaloCyte which have been covered by us in this article and also you can find KaloCyte patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over KaloCyte patent portfolio.

How many patents does KaloCyte have?

KaloCyte has a total of 19 patents globally. These patents belong to 4 unique patent families. Out of 19 patents, 17 patents are active.

How Many Patents did KaloCyte File Every Year?

KaloCyte Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKaloCyte Applications FiledKaloCyte Patents Granted
202331
20228
20218

How many KaloCyte patents are Alive/Dead?

Worldwide Patents

KaloCyte Patent Portfolio

How Many Patents did KaloCyte File in Different Countries?

KaloCyte Worldwide Patent Filing

Countries in which KaloCyte Filed Patents

CountryPatent
United States Of America2
Mexico2
Australia2
Brazil2
Canada2
South Africa2
Japan1
Europe1
Korea (South)1
Hong Kong (S.A.R.)1
India1

Where are Research Centers of KaloCyte Patents Located?

R&D Centres of KaloCyte

What Percentage of KaloCyte US Patent Applications Were Granted?

KaloCyte (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.

Below are the key stats of KaloCyte patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for KaloCyte?

Law FirmTotal ApplicationsSuccess Rate
Whiteford Taylor & Preston Llp20%

List of KaloCyte patents

KaloCyte PatentsTitle
US20220287984A1Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids
US20210330754A1Self-Assembling Oxygen Carrier Compositions
EP4138855A1Self-Assembling Oxygen Carrier Compositions
CA3210619A1Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids
CA3175425A1Self-Assembling Oxygen Carrier Compositions
AU2022232631A1Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids
AU2021261405A1Self-Assembling Oxygen Carrier Compositions
JP2023523033ASelf-Assembling Oxygen Carrier Composition
HK40085835ASelf-Assembling Oxygen Carrier Compositions
BR112023018210A2Compositions And Methods For Removing Biosynthetic Nanoparticles From Body Fluids
BR112022021291A2Self-Assembly Oxygen Vehicle Compositions
IN202227060381ASelf-Assembling Oxygen Carrier Compositions
ZA202211495BSelf-Assembling Oxygen Carrier Compositions
MX2023010613ACompositions And Methods For Removing Biosynthetic Nanoparticles From Body Fluids
ZA202308676ACompositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids
KR1020230005285ASelf-Assembling Oxygen Carrier Composition
MX2022013213ASelf-Assembled Oxygen Carrier Compositions
WO2022192619A1Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids
WO2021217010A1Self-Assembling Oxygen Carrier Compositions

What are KaloCyte key innovation segments?

What Technologies are Covered by KaloCyte?

The chart below distributes patents filed by KaloCyte in different countries on the basis of the technology protected in patents. It also represents the markets where KaloCyte thinks it’s important to protect particular technology inventions.

R&D Focus: How has KaloCyte search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by KaloCyte?

Related Articles

Tormek Patents – Insights & Stats (Updated 2024)

Tormek has a total of 100 patents globally, out of which 89 have been granted. Of these 100 patents, more than 73% patents are active. Europe (EPO) is where Tormek has filed the maximum number of patents, followed by United States of America and Germany. Parallelly, Sweden seems to be

Read More »

Absolent Patents – Insights & Stats (Updated 2024)

Absolent has a total of 30 patents globally, out of which 18 have been granted. Of these 30 patents, more than 60% patents are active. Sweden is where Absolent has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Sweden seems to be

Read More »

Modvion Patents – Insights & Stats (Updated 2024)

Modvion has a total of 44 patents globally, out of which 15 have been granted. Of these 44 patents, more than 68% patents are active. Sweden is where Modvion has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Sweden seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.